Use of the Spot Vision Screener for patients with developmental disability.

Purpose: To determine whether the Spot Vision Screener effectively detects amblyopia risk factors (ARFs) in patients with developmental disability using the 2013 guidelines of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS).

Methods: Children with developmental disability presenting for complete pediatric ophthalmologic examination were prospectively enrolled between June 2012 and March 2016. The following data were analyzed: presence of ARFs according to the AAPOS guidelines, refraction, eye alignment, and other ocular pathology.

Performance of the Spot Vision Screener in Children Younger Than 3 Years of Age.

Purpose: To evaluate the use of the Spot Vision Screener (Spot; Welch Allyn, Skaneateles Falls, New York, USA) for detection of amblyopia risk factors in children aged 6 months to 3 years, as defined by the 2013 guidelines of the American Association for Pediatric Ophthalmology and Strabismus.

Design: Reliability analysis.

Methods: In this study, children seen from June 1, 2012, to April 30, 2016 were tested with the Spot during a routine visit.